Uveal melanoma impacts approximately 500 to 600 individuals annually in the UK.

Vaccine Stock #2: Moderna Moderna, Inc. (MRNA), founded in 2010 and headquartered in Cambridge, Massachusetts, is a biotech pioneer with a $14.2 billion market cap.

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved. Since the end of 2021, even the approved ...

Other vaccine-related companies also felt the fallout. German company BioNTech closed 7% lower, and British GSK fell 2%. US vaccine companies have already been struggling, thanks to lessened demand ...

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...

Surely, it’s not just a coincidence that Novavax stock catapulted higher in mid-May, during the resurgence of meme-stock mania. This wasn’t just a relief rally for COVID-19 vaccine stocks; it ...

Asia Global stocks mixed amid vaccine, stimulus optimism BEIJING - Global stock markets were mixed Monday amid optimism about government stimulus and the rollout of coronavirus vaccines.